TrialReader


Cortical Excitability and Role of rTMS in Nicotine Use Disorder

NCT03264755 — Not applicable, Unknown, 60 participants, Assiut University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03264755
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment60 (Estimated)
SponsorAssiut University (Other)
ConditionsNicotine Use Disorder
InterventionsRepetitive transcranial magnetic stimulation (Device)
Datesstart 2020-05-04 (estimated), primary completion 2020-12-04 (estimated), completion 2020-12-04 (estimated), first posted 2017-08-29, last updated 2020-03-10

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Nicotine Use Disorder All trials of Repetitive transcranial magnetic stimulation

-Summary

Cortical excitability and role of repetitive transcranial magnetic stimulation in nicotine use disorder. Estimation of cortical excitability in heavy smoker patients and determination of role of repetitive transcranial magnetic stimulation for reducing nicotine craving.

Expand all sections  ·  Collapse all

+Detailed description

Nicotine is one of the main components of cigarettes and affects the central nervous system mainly via nicotinic acetylcholine receptors. It has further effects on neuromodulation by regulating the release of dopamine, serotonin, glutamate and adrenaline. In studies, it has been shown that nicotine improves attention and working memory in animals and humans, while nicotine withdrawal leads to reduced working and verbal memory capacity in otherwise healthy tobacco smokers. In schizophrenics and patients suffering from attention deficit hyperactivity disorder, nicotine improves cognitive performance. A likely basis of the nicotinic effects on cognitive functions is its effect on cortical excitability and activity. Here, neurophysiological studies mainly base on animal experiments and have shown in vitro that the nicotinic acetylcholine receptors elicit neuronal depolarisation by inducing transmembrane cationic inward currents (Calcium), thus being involved in induction and modulation of neuroplasticity and cortical excitability.

Repetitive transcranial magnetic stimulation: is a non-invasive brain stimulation technique that has shown positive results in the treatment of depression, schizophrenia, and more recently addiction. Repetitive transcranial magnetic stimulation uses alternating magnetic fields to induce electric currents in the cortical tissue. Low-frequency as one hertz repetitive transcranial magnetic stimulation is believed to inhibit neuronal firing in a localized area and is used to induce virtual brain lesions. High-frequency as more than three hertz repetitive transcranial magnetic stimulation is believed to be excitatory in nature and can result in neuronal depolarization under the stimulating coil. However, the effects of repetitive transcranial magnetic stimulation are not limited to the site of stimulation and can induce changes in distant interconnected sites of the brain, and consequently may influence subcortical regions.

+Arms and interventions

ArmTypeInterventionsDescription
cortical excitability in smokersActive comparatorDevice: Repetitive transcranial magnetic stimulation
cortical excitability in nonsmokersActive comparatorDevice: Repetitive transcranial magnetic stimulation
  • Repetitive transcranial magnetic stimulation (Device): Repetitive transcranial magnetic stimulation for cortical excitability in smokers and non smokers

+Outcome measures

Primary outcomes

  • Comparison of cortical excitability between smoker and non smoker [24 month]: Comparison of cortical excitability between smoker and non smoker :The primary motor cortex served as model, and cortical excitability was monitored via transcranial magnetic stimulation (TMS).

+Eligibility

Sex: Male, ages: 18 Years to 50 Years, accepts healthy volunteers

Inclusion Criteria:

1 )patients must be 18 to 50 years of age. 2) heavy smokers (daily cigarettes consumption of more than 20 pieces.)

Exclusion Criteria:

1. cardiac pacemaker.
2. metal implants in the head.
3. Renal diseases

+Publications

  • Results publication: Abdelrahman AA, Noaman M, Fawzy M, Moheb A, Karim AA, Khedr EM. A double-blind randomized clinical trial of high frequency rTMS over the DLPFC on nicotine dependence, anxiety and depression. Sci Rep. 2021 Jan 15;11(1):1640. doi: 10.1038/s41598-020-80927-5. PMID 33452340

My Notes